Arcotatug
Based on 1 Customer Validation
Arcotatug (IBI-343 antibody) is a CLDN18.2 targeting humanized monoclonal antibody. Arcotatug can be used for synthesis of ADCs.
商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。
- 純度: 98%
- CAS 番号: 3031170-61-0
- 分子量:145.647 kDa
-
保管条件:
Please store the product under the recommended conditions in the Certificate of Analysis.
生物活性
Human IgG1 kappa
Human
|
CLDN18.2 |
Arcotatug can be used to synthesize ADC Arcotatug tavatecan (IBI343), which shows anticancer activity in gastric or gastroesophageal junction adenocarcinoma[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Unconjugated
The product can be reconstituted/diluted with sterile PBS or saline.
-
IgG1-kappa
ELISA, FACS, Functional assay
化学情報
-
CAS 番号 3031170-61-0
-
性状 Liquid
-
分子量 145.647 kDa
-
Color Colorless to light yellow
-
SMILES
N/A
-
別名
IBI-343 antibody; HB37A6; TAK-921 Antibody
-
輸送条件
Shipping with dry ice.
-
Formulation
Please refer to the lot-specific COA for specific buffer information.
-
保管条件
Please store the product under the recommended conditions in the Certificate of Analysis.
純度とドキュメンテーション
-
データシート (256 KB)
-
SDS (251 KB)
- English - EN (251 KB)
- Français - FR (251 KB)
- Deutsch - DE (251 KB)
- Norwegian - NO (251 KB)
- Español - ES (251 KB)
- Swedish - SV (251 KB)
- Italian - IT (251 KB)
- Korean - KR (251 KB)
- Portuguese - PT (251 KB)
-
Inhibitory Antibodies User Guide (603 KB)
参考文献
Calculators
濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)
- Arcotatug
- 3031170-61-0
- IBI-343 antibody
- HB37A6
- TAK-921 Antibody
- ADC Antibodies
- Claudin
- antibody-dependent cellular cytotoxicity
- complement-dependent cytotoxicity
- CLDN18.2
- IgG1 Fc silencing
- pancreatic ductal adenocarcinoma
- topoisomerase I
- gastric adenocarcinoma
- gastroesophageal junction adenocarcinoma
- biliary tract cancer
- Inhibitor
- inhibitor
- inhibit